November 2, 2017 / 11:49 AM / a month ago

BRIEF-Aviragen Therapeutics Q1 loss per share $0.14

Nov 2 (Reuters) - Aviragen Therapeutics Inc

* Aviragen Therapeutics reports first quarter of fiscal year 2018 financial results

* Q1 loss per share $0.14

* Q1 revenue $100,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below